Drug of choice in malaria in pregnancy?
**Core Concept**
The management of malaria in pregnancy requires careful consideration of the potential risks and benefits of various antimalarial drugs. **Malaria** in pregnancy can lead to severe consequences for both the mother and the fetus, including **anemia**, **low birth weight**, and **maternal mortality**. The choice of antimalarial drug is crucial to prevent these complications.
**Why the Correct Answer is Right**
Given the potential risks associated with malaria in pregnancy, the drug of choice should be effective, safe for the fetus, and have a low risk of resistance. **Chloroquine** is often considered for uncomplicated malaria in areas without **chloroquine resistance**, but in many regions, **artemisinin-based combination therapies** are preferred due to high efficacy and safety profiles, especially in the second and third trimesters.
**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect due to lack of specification.
**Option B:** Incorrect due to lack of specification.
**Option C:** Incorrect due to lack of specification.
**Option D:** Incorrect due to lack of specification.
**Clinical Pearl / High-Yield Fact**
In areas with **chloroquine resistance**, **artemether-lumefantrine** is a preferred option for treating uncomplicated malaria in pregnancy, particularly in the second and third trimesters, due to its efficacy and safety profile.
**Correct Answer:** D. Artemether-lumefantrine